PTSD Mobile App for Cancer Survivors
Trial Summary
What is the purpose of this trial?
The purpose of this study is to use a stepped-care approach in treating symptoms of posttraumatic stress disorder (PTSD). The information learned by doing this study may help us to develop some target treatments for PTSD symptoms in survivors of stem cell transplant. Participants in this study will be randomized to a mobile app or usual care. An assessment will be made after 4 weeks and a determination made of adding more intensive treatment. Participants will be asked to complete a questionnaire 4 times over a period of 6 months, at the time your participation is complete.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the idea that PTSD Mobile App for Cancer Survivors is an effective treatment?
The available research shows that mobile app-based interventions, like the PTSD Mobile App for Cancer Survivors, can help reduce symptoms of distress in cancer survivors. For example, one study highlights that these apps can increase access to mental health care for survivors of women's cancer, who often face barriers to in-person treatment. Another review suggests that mobile health applications can improve mental health in breast cancer survivors. While specific data on the PTSD Mobile App for Cancer Survivors is limited, these findings suggest that mobile health interventions can be beneficial for managing psychological distress in cancer survivors.12345
What safety data exists for the PTSD Mobile App for Cancer Survivors?
The available research does not directly address safety data for the PTSD Mobile App for Cancer Survivors. However, related studies on app-based cognitive-behavioral stress management interventions for cancer survivors, such as Stress Proffen, indicate positive outcomes in reducing stress, anxiety, and self-regulatory fatigue, and improving quality of life. These studies suggest that such interventions are generally well-received and considered useful and accessible by participants, but specific safety data is not detailed in the provided abstracts.678910
Is the Cancer Distress Coach (CaDC) App a promising treatment for cancer survivors with PTSD?
Yes, the Cancer Distress Coach (CaDC) App is a promising treatment because it offers a personalized approach to help cancer survivors manage PTSD symptoms. It uses a smart design to adapt to each person's needs, making it easier for them to get the right support. Mobile apps like this can also make mental health care more accessible to people who might not be able to attend in-person therapy.12111213
Research Team
Sophia K Smith, PhD, MSW
Principal Investigator
Duke University
Eligibility Criteria
This trial is for cancer survivors who've had a stem cell transplant 1-5 years ago and are showing signs of PTSD but haven't received CBT for it. They must be able to use a smart device, read/write English, have their oncologist's approval, and not be severely psychologically impaired.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Treatment
Participants are randomized to a mobile app or usual care. An assessment will be made after 4 weeks.
Intensive Treatment
Based on the 4-week assessment, more intensive treatment may be added.
Follow-up
Participants are monitored for changes in distress, anxiety, self-efficacy, PTSD symptoms, depression, and quality of life.
Treatment Details
Interventions
- CaDC + mCoaching (Behavioural Intervention)
- Cancer Distress Coach (CaDC) App (Behavioural Intervention)
- mCBT (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
Mary E. Klotman
Duke University
Chief Executive Officer since 2017
MD from Duke University School of Medicine
Michelle McMurry-Heath
Duke University
Chief Medical Officer since 2020
MD from Duke University School of Medicine